Pheochromocytoma as a catecholamine producing tumor: implications for clinical practice

Area of Science:

• Endocrinology
• Oncology
• Genetics

Background:

• Pheochromocytomas are rare tumors that produce excess catecholamines.
• Uncontrolled catecholamine secretion can lead to life-threatening cardiovascular events.
• Diagnosis is crucial for patients with symptoms, adrenal incidentalomas, or genetic predispositions.

Purpose of the Study:

• To summarize the key aspects of pheochromocytoma diagnosis, localization, treatment, and follow-up.
• To highlight the importance of biochemical testing and genetic screening.
• To emphasize the necessity of pre-treatment and post-operative monitoring.

Main Methods:

• Review of clinical presentation, diagnostic criteria, and imaging techniques (CT, MRI, [(123)I]-MIBG).
• Discussion of genetic testing for hereditary syndromes (MEN2, VHL, NF1, SDH mutations).
• Outline of pre-operative medical management and surgical approaches (laparoscopy).

Main Results:

• Early and accurate diagnosis significantly reduces mortality.
• Multimodality imaging aids in precise tumor localization.
• Surgical resection is the primary treatment, with laparoscopy being preferred.
• Post-operative surveillance is essential for detecting recurrence or metastasis.

Conclusions:

• Pheochromocytoma management requires a multidisciplinary approach.
• Timely diagnosis, appropriate treatment, and vigilant follow-up are critical for optimal patient outcomes.
• Despite excellent prognosis post-resection, lifelong monitoring is mandatory due to potential for recurrence.